LEG vs. ABBV
LEG (Leggett & Platt, Incorporated) and ABBV (AbbVie Inc.) are both stocks. LEG operates in Furnishings, Fixtures & Appliances (Consumer Cyclical), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, LEG returned -12.01%/yr vs 18.94%/yr for ABBV. Their 0.26 correlation means their historical movements had little consistent relationship.
Performance
LEG vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LEG achieves a -10.05% return, which is significantly lower than ABBV's 12.42% return. Over the past 10 years, LEG has underperformed ABBV with an annualized return of -12.01%, while ABBV has yielded a comparatively higher 18.94% annualized return.
LEG
- 1D
- -2.20%
- 1M
- -16.02%
- 6M
- -15.21%
- YTD
- -10.05%
- 1Y
- 4.60%
- 3Y*
- -29.16%
- 5Y*
- -24.27%
- 10Y*
- -12.01%
- ALL TIME*
- 6.33%
ABBV
- 1D
- -2.51%
- 1M
- 0.66%
- 6M
- 14.27%
- YTD
- 12.42%
- 1Y
- 36.88%
- 3Y*
- 23.28%
- 5Y*
- 20.99%
- 10Y*
- 18.94%
- ALL TIME*
- 20.35%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
ABBV AbbVie Inc. | $1.40B | $1.53B | $1.60B |
| $18.50M | $23.27M | $28.03M |
LEG vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LEG Leggett & Platt, Incorporated | -10.05% | 17.02% | -61.93% | -13.45% | -17.78% | -3.76% | -9.05% | 47.13% | -22.25% | 0.58% |
ABBV AbbVie Inc. | 12.42% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between LEG and ABBV is 0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.07 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.16 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.26 |
The correlation between LEG and ABBV shifts across timeframes, from 0.07 (1 year) to 0.26 (all time), reflecting how their relationship changes across market environments.
Fundamentals
LEG:
$1.34B
ABBV:
$443.24B
LEG:
$1.60
ABBV:
$2.05
LEG:
6.13
ABBV:
122.29
LEG:
0.45
ABBV:
7.08
LEG:
1.33
ABBV:
16.19
LEG:
$3.03B
ABBV:
$62.82B
LEG:
$717.40M
ABBV:
$46.15B
LEG:
$433.10M
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LEG vs. ABBV — Risk / Return Rank
LEG
ABBV
LEG vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Leggett & Platt, Incorporated (LEG) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LEG | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.32 | ||
| Sortino ratioReturn per unit of downside risk | -1.58 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.26 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 0.16 | 2.14 | -1.98 |
| Martin ratioReturn relative to average drawdown | 0.34 | 4.73 | -4.39 |
Loading charts...
Drawdowns
LEG vs. ABBV - Drawdown Comparison
The maximum LEG drawdown since its inception was -86.41%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for LEG and ABBV.
Loading charts...
Drawdown Indicators
| LEG | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.41% | -45.09% | -41.32% |
Max Drawdown (1Y)Largest decline over 1 year | -28.51% | -17.32% | -11.19% |
Max Drawdown (3Y)Largest decline over 3 years | -76.68% | -20.74% | -55.94% |
Max Drawdown (5Y)Largest decline over 5 years | -84.29% | -21.92% | -62.37% |
Max Drawdown (10Y)Largest decline over 10 years | -86.41% | -45.09% | -41.32% |
Current DrawdownCurrent decline from peak | -79.20% | -4.69% | -74.51% |
Average DrawdownAverage peak-to-trough decline | -19.84% | -10.64% | -9.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.72% | 7.81% | +5.91% |
Volatility
LEG vs. ABBV - Volatility Comparison
Leggett & Platt, Incorporated (LEG) has a higher volatility of 11.32% compared to AbbVie Inc. (ABBV) at 8.35%. This indicates that LEG's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LEG | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.32% | 8.35% | +2.97% |
Volatility (6M)Calculated over the trailing 6-month period | 32.38% | 19.56% | +12.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.36% | 26.14% | +23.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.74% | 23.46% | +19.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.96% | 25.92% | +14.04% |
Dividends
LEG vs. ABBV - Dividend Comparison
LEG's dividend yield for the trailing twelve months is around 2.04%, less than ABBV's 2.72% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.72% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
LEG Leggett & Platt, Incorporated | 2.04% | 1.82% | 6.35% | 6.95% | 5.40% | 4.03% | 3.61% | 3.11% | 4.19% | 2.98% | 2.74% | 3.00% |
Financials
LEG vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Leggett & Platt, Incorporated and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
LEG and ABBV have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LEG has higher volatility (11.32%) compared to ABBV (8.35%). In terms of maximum drawdown, LEG dropped -86.41% vs ABBV's -45.09%.
ABBV currently has the higher Sharpe Ratio (1.42 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LEG and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer